11.86
02-5月-25 15:45:00
15 分の遅延
株式
-0.13
-1.08%
本日の幅
11.80 - 12.47
ISIN
N/A
ソース
NASDAQ
Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study
10 1 2021 14:00:00 提供 Nasdaq GlobeNewswire
Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
05 1 2021 06:30:00 提供 Nasdaq GlobeNewswire